Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Two-Photon Research is a Canadian deep-technology company developing aptamer-based discovery tools and photonic diagnostic devices. Its healthcare-related activities center on computational synthesis and validation of aptamers and high-sensitivity in vitro diagnostic systems for biomarker detection and monitoring. The company markets AptaSoft for aptamer design and describes CAST as a bio-photonic diagnostics platform with femtomolar sensitivity, including use cases in pathogen detection such as SARS-CoV-2. Beyond health applications, the company also works in photonics, GaN and GeSn devices, microelectronics, and direct-write lithography. Overall, it appears to be a platform-oriented private company operating at the intersection of molecular diagnostics, photonics, and microfabrication.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Two-Photon Research.